David Feinberg, M.D., is president and CEO of Geisinger located in Danville, Pennsylvania, one of the nation’s most innovative health services organizations which includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers, and a school of medicine. With a focus on caring for patients and members, Dr. Feinberg launched SpringBoard Health®, a population health initiative to improve the health of all of Scranton, Pennsylvania; Geisinger’s ProvenExperience™, to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world that is returning medically actionable results to participants while conducting extensive research. Prior to joining Geisinger, Dr. Feinberg served as CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System. Recognized nationally as a top healthcare leader, Modern Healthcare named Dr. Feinberg as one of the “100 Most Influential People in Healthcare” and he was ranked third on the 2017 “Most Influential Physician Executives and Leaders” list. A well-known national speaker and author of numerous articles, Dr. Feinberg is a member of the Alpha Omega Alpha Medical Honor Society, a Distinguished Fellow of the American Psychiatric Association, and received the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry. Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley. He graduated with distinction from the University of Health Sciences/Chicago Medical School. He completed an internship in pediatrics at Loyola University Medical Center, and residency and fellowship training in psychiatry, addiction psychiatry, and child and adolescent psychiatry at the UCLA School of Medicine. He earned an MBA from Pepperdine University.